This hypothesis is further supported by higher levels of CD4+/CD25+/FoxP3+ Tregs in mice with severe disease, indicating that CD4+/CD25+/FoxP3+ Tregs might reduce virus-specific CD8+ T cell effector function, which has also been demonstrated for hepatitis C virus infections (39). The gene discussed is CD4; the disease is hepatitis C virus infection.